Sagility Limited, a healthcare services company, has announced significant changes in its financial leadership team. The company disclosed these changes in a recent filing with the stock exchanges, highlighting a transition in its top financial roles.

Key Leadership Changes

CFO Resignation

Sarvabhouman Doraiswamy Srinivasan, the Group Chief Finance Officer and a Key Managerial Personnel of Sagility Limited, has submitted his resignation. The company's board has acknowledged and accepted the resignation, which will take effect from the close of business on November 15, 2025. Mr. Srinivasan cited personal reasons for his departure in his resignation letter dated November 3, 2025.

The board of Sagility Limited expressed its appreciation for Mr. Srinivasan's valuable contributions during his tenure with the company.

New Appointment

In light of this change, the board has approved the appointment of Abhishek Kayan as Deputy CFO and a Senior Management Personnel (SMP). This decision was made based on recommendations from the Nomination & Remuneration Committee and the Audit Committee.

About Abhishek Kayan

Abhishek Kayan brings a wealth of experience to his new role:

• 20 years of experience in the healthcare services sector
• Expertise across key finance functions, including Business Finance, Pricing, FP&A, Corporate Treasury, and Investor Relations
• Currently serves as the Group Head of FP&A & IR and Head of Finance for the Americas region at Sagility
• Holds an MBA from the Indian Institute of Management, Lucknow
• Possesses a bachelor's degree in technology from West Bengal University of Technology

These changes in Sagility's financial leadership team come as the company continues to operate in the healthcare services sector. The transition in key financial roles may indicate a shift in the company's financial strategy and operations.

Sagility Limited (ISIN: INE0W2G01015) has reported robust financial results for the second quarter of fiscal year 2026, showcasing significant growth across key metrics and prompting an upward revision of its full-year guidance.

Financial Highlights

Sagility's consolidated revenues for Q2 FY26 reached INR 16,585 million ($189.4 million), marking a substantial year-on-year growth of 25.2% in INR terms and 20% in constant currency. The company's organic growth remained strong at 16% year-on-year in INR terms and 11.1% in constant currency.

The company's profitability showed impressive improvement, with adjusted EBITDA reaching INR 4,352 million ($49.8 million), representing a 25.6% year-on-year increase and a robust margin of 26.2%.

Segment Performance

Payer Business

• Grew 24.2% year-on-year
• Contributed 88.5% to total revenue

Provider Vertical

• Expanded 33.4% year-on-year
• Accounted for 11.5% of overall revenues

Client Acquisition and Business Wins

Sagility secured business from 24 existing clients and added five new clients during the quarter. The aggregate annual contract value (ACV) of new wins stood at $34 million, including contracts with:

• A regional Blues plan
• A provider of home medical supplies and equipment
• A regional healthcare organization offering integrated clinic-based services with a health insurance plan

AI and Technology Initiatives

The company has successfully deployed 25 distinct AI use cases across nine clients, demonstrating its commitment to leveraging advanced technologies for improved service delivery and operational efficiency.

Outlook and Guidance

Given the strong momentum, Sagility has raised its full-year guidance for FY2026:

• Constant currency revenue growth: Increased to 21% plus (from previous 20%)
• Adjusted EBITDA: Revised to close to 25% (from previous 24% plus)

Management Commentary

Ramesh Gopalan, Managing Director and Group CEO, stated, "Our focus on execution remains steadfast, supported by the ongoing strengthening of our AI and technology capabilities. These have helped us deepen engagement with existing clients and extend our reach into the mid-market space."

Dividend Announcement

The Board of Directors has approved an interim dividend of INR 0.05 per share, to be paid in Q3.

Sagility's strong performance in Q2 FY26, coupled with its strategic focus on AI and technology-driven solutions, positions the company well for continued growth in the evolving healthcare services landscape.